These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32535903)

  • 1. Impact of atrial fibrillation in critically ill patients admitted to a stepdown unit.
    Falsetti L; Proietti M; Zaccone V; Guerra F; Nitti C; Salvi A; Viticchi G; Riccomi F; Sampaolesi M; Silvestrini M; Moroncini G; Lip GYH; Capucci A
    Eur J Clin Invest; 2020 Nov; 50(11):e13317. PubMed ID: 32535903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program.
    McIntyre WF; Conen D; Olshansky B; Halperin JL; Hayek E; Huisman MV; Lip GYH; Lu S; Healey JS
    Clin Cardiol; 2018 Jun; 41(6):744-751. PubMed ID: 29546729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF.
    Verheugt FWA; Ambrosio G; Atar D; Bassand JP; Camm AJ; Costabel JP; Fitzmaurice DA; Illingworth L; Goldhaber SZ; Goto S; Haas S; Jansky P; Kayani G; Stepinska J; Turpie AGG; van Eickels M; Kakkar AK;
    Am J Med; 2019 Dec; 132(12):1431-1440.e7. PubMed ID: 31306621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
    Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
    BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of atrial fibrillation: a retrospective review of patients presenting to acute medical services.
    Jolliffe E; Fu V; Lanford J; Weatherall M; Rosemergy I
    Intern Med J; 2016 Oct; 46(10):1166-1171. PubMed ID: 27501863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, treatment and mortality of new-onset atrial fibrillation patients at the intensive care unit.
    Jacobs MS; Loef B; Reidinga AC; Postma MJ; Van Hulst M; Tieleman RG
    Open Heart; 2020; 7(1):e001226. PubMed ID: 32509315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure.
    Savarese G; Sartipy U; Friberg L; Dahlström U; Lund LH
    Heart; 2018 Jul; 104(13):1093-1100. PubMed ID: 29371374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do CHA2 DS2 VASc and HAS-BLED scores influence 'real-world' anticoagulation management in atrial fibrillation? 1556 patient registry from the reference cardiology centre.
    Lopatowska P; Tomaszuk-Kazberuk A; Mlodawska E; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S; Musial WJ
    Pharmacoepidemiol Drug Saf; 2015 Dec; 24(12):1297-303. PubMed ID: 26419506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk prediction of clinical adverse outcomes with machine learning in a cohort of critically ill patients with atrial fibrillation.
    Falsetti L; Rucco M; Proietti M; Viticchi G; Zaccone V; Scarponi M; Giovenali L; Moroncini G; Nitti C; Salvi A
    Sci Rep; 2021 Sep; 11(1):18925. PubMed ID: 34556682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.
    McGrath ER; Go AS; Chang Y; Borowsky LH; Fang MC; Reynolds K; Singer DE
    J Am Geriatr Soc; 2017 Feb; 65(2):241-248. PubMed ID: 28039855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Retrospective Observational Study of Anticoagulation Practices in Critically ill Patients with Atrial Fibrillation Admitted to the Intensive Care Unit.
    Miller N; Johnston BW; Hampden-Martin A; Aac W; Waugh V; Welters ID
    J Intensive Care Med; 2022 Dec; 37(12):1569-1579. PubMed ID: 35450462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry.
    O'Brien EC; Kim S; Thomas L; Fonarow GC; Kowey PR; Mahaffey KW; Gersh BJ; Piccini JP; Peterson ED
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How well does physician risk assessment predict stroke and bleeding in atrial fibrillation? Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
    Steinberg BA; Shrader P; Kim S; Thomas L; Fonarow GC; Ansell J; Kowey PR; Singer DE; Gersh BJ; Mahaffey KW; Peterson ED; Piccini JP;
    Am Heart J; 2016 Nov; 181():145-152. PubMed ID: 27823686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation.
    Fox KAA; Lucas JE; Pieper KS; Bassand JP; Camm AJ; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Hacke W; Kayani G; Oto A; Mantovani LG; Misselwitz F; Piccini JP; Turpie AGG; Verheugt FWA; Kakkar AK;
    BMJ Open; 2017 Dec; 7(12):e017157. PubMed ID: 29273652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GARFIELD-AF model for prediction of stroke and major bleeding in atrial fibrillation: a Danish nationwide validation study.
    Dalgaard F; Pieper K; Verheugt F; Camm AJ; Fox KA; Kakkar AK; Pallisgaard JL; Rasmussen PV; Weert HV; Lindhardt TB; Torp-Pedersen C; Gislason GH; Ruwald MH; Harskamp RE
    BMJ Open; 2019 Nov; 9(11):e033283. PubMed ID: 31719095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flaws in Anticoagulation Strategies in Patients With Atrial Fibrillation at Hospital Discharge.
    Kartas A; Samaras A; Vasdeki D; Dividis G; Fotos G; Paschou E; Forozidou E; Tsoukra P; Kotsi E; Goulas I; Efthimiadis G; Karvounis H; Tzikas A; Giannakoulas G
    J Cardiovasc Pharmacol Ther; 2019 May; 24(3):225-232. PubMed ID: 30599759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation.
    O'Brien EC; Holmes DN; Thomas LE; Fonarow GC; Allen LA; Gersh BJ; Kowey PR; Singer DE; Ezekowitz MD; Naccarelli GV; Ansell JE; Chan PS; Mahaffey KW; Go AS; Freeman JV; Reiffel JA; Peterson ED; Piccini JP; Hylek EM
    Circulation; 2018 Aug; 138(9):889-897. PubMed ID: 29678813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regular Bleeding Risk Assessment Associated with Reduction in Bleeding Outcomes: The mAFA-II Randomized Trial.
    Guo Y; Lane DA; Chen Y; Lip GYH;
    Am J Med; 2020 Oct; 133(10):1195-1202.e2. PubMed ID: 32289310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the Atrial Fibrillation undergoing Coronary Artery Stenting study.
    Schlitt A; Rubboli A; Lip GY; Lahtela H; Valencia J; Karjalainen PP; Weber M; Laine M; Kirchhof P; Niemelä M; Vikman S; Buerke M; Airaksinen KE;
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E864-70. PubMed ID: 23765437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.